Comprehensive Management of Dravet Syndrome

Joseph Sullivan, MD, and Elaine C. Wirrell, MD, discuss the presentation of Dravet syndrome in children.

The importance of early diagnosis of Dravet syndrome as well as seizure triggers and comorbidities are discussed by key opinion leaders in the field.

Elaine C. Wirrell, MD, explains the increased risk of sudden unexpected death in epilepsy (SUDEP) in patients with Dravet syndrome and how to talk about it with caregivers and families.

Considerations of genetic testing regarding family planning as well as behavioral issues associated with Dravet syndrome.

Experts discuss the goals of treatment of patients with Dravet syndrome regarding seizure freedom and seizure burden.

Joseph Sullivan, MD, and Elaine C. Wirrell, MD, discuss the management of seizures for Dravet syndrome with different approved therapies.

Elaine C. Wirrell, MD, provides an overview of cannabidiol oral solution for treatment of seizures associated with Dravet syndrome.

Joseph Sullivan, MD, provides an overview of the recent approval of fenfluramine oral solution for the treatment of Dravet syndrome.

The impact of new drug approvals on the consensus guidelines for the treatment of Dravet syndrome.

A discussion of new developments for the treatment of Dravet syndrome beyond seizure control including gene editing and therapy.

Key opinion leaders discuss managing patient expectations regarding clinical trials for Dravet syndrome treatment.

Joseph Sullivan, MD, and Elaine C. Wirrell, discuss the transition of care into adulthood of patients with Dravet syndrome.